Peripheral Blood vs Bone Marrow Grafts for Aplastic Anemia
Part of Blood & lymphatic clinical trials.
This trial tests two different sources of donor cells for a transplant in patients with severe aplastic anemia (a condition where the bone marrow stops making enough blood cells). The study compares using cells from blood alone versus cells from both bone marrow and blood, to see which approach works better.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Diagnosed with severe aplastic anemia or very severe aplastic anemia (low blood cell counts and low bone marrow activity)
- Age 18 to 40 years old
- Have a haploidentical (half-matched) relative who can donate bone marrow or blood cells
- Good heart, liver, and kidney function
- No active infections or history of previous stem cell or organ transplant
- Able to use effective birth control during the study and willing to sign consent forms
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new way to treat severe aplastic anemia by combining a stem cell transplant from a half-matched donor with special stem cells from umbilical cord blood. The goal is to help your body make healthy blood cells again.
This trial tests a stem cell transplant from a closely matched but not fully matched family donor (haploidentical), with chemotherapy after the transplant to help prevent graft-versus-host disease (GVHD). It may help people with severe aplastic anemia, certain MDS after transformation, or PNH when other treatments have not worked or are not available.
This trial tests a combination of four medicines (cyclosporine, eltrombopag or hetrombopag, romiplostim, and supportive care) for newly diagnosed aplastic anemia—a serious blood disorder where the bone marrow stops making enough blood cells. The goal is to help your bone marrow work better and reduce your need for blood transfusions.
This trial tests whether an early bone marrow transplant from a half-matched family member or an unrelated donor can help people with severe aplastic anemia. It aims to restore the body's ability to make healthy blood cells.
This trial tests a new type of transplant using donated cord blood for adults with aplastic anemia that has not improved with standard treatments. It aims to see if the transplant is safe and effective.
This study tests whether adding umbilical cord blood to a stem cell transplant from a half-matched donor can improve outcomes for people with severe aplastic anemia or related bone marrow failure diseases.
Hear when a new Severe Aplastic Anemia (SAA) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.